Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund's Pfizer Inc Holding Summary
As of 2023-09-30, Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund held 12,440.00 shares of Pfizer Inc(PFE), totaling $412,630.00. This investment constitutes 2.7% of their stock portfolio, and Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund now holds 0% of the outstanding Pfizer Inc(PFE) stock.
The initial trade took place in 2019Q3. And since then Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund has made 8 purchases of PFE, at an average price of $42.52, for a total of 32,968.00 shares. In addition, there have been 4 sales at an average price of $38.17 for 20,528.00 shares. Based on historical transaction data and PFE's current price of $24.03, Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund's estimated gain on his PFE holdings is $-319,282.84, reflecting a -22.78% gain to date.
Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund PFE ($24.03) Holding Chart
Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund PFE ($24.03) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
